Article Information
History
- August 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Thibaut Vanbaelen, MD1,*,
- Achilleas Tsoumanis, PhD1,
- Eric Florence, PhD1,2,
- Christophe Van Dijck, PhD1,
- Diana Huis in ‘t Veld, PhD3,
- Anne-Sophie Sauvage4,
- Natacha Herssens1,
- Irith De Baetselier, PhD1,
- Anke Rotsaert5,
- Veronique Verhoeven, PhD6,
- Sophie Henrard8,
- Yven Van Herrewege, PhD1,
- Dorien Van den Bossche, PhD1,
- Jean-Christophe Goffard, PhD8,
- Elizaveta Padalko, PhD9,
- Thijs Reyniers, PhD5,
- Bea Vuylsteke, PhD5,
- Marie-Pierre Hayette10,
- Agnes Libois7,# and
- Prof. Chris Kenyon, PhD1,#
- 1Department of clinical sciences, Institute of Tropical Medicine Antwerp, Belgium
- 2Department of General Internal Medicine, Infectious Diseases and Tropical Medicine, University Hospital of Antwerp, Belgium
- 3Department of Infectious Diseases, Ghent University Hospital, Gent, Belgium
- 4Department of Infectious Diseases, Liège University Hospital, Liège, Belgium
- 5Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
- 6Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium
- 7Department of Infectious Diseases, Saint Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium
- 8Department of Infectious Diseases, Erasme University Hospital, Université Libre de Bruxelles, Brussels: Belgium
- 9Department of Medical Microbiology, Ghent University Hospital, Ghent, Belgium
- 10Department of Clinical Microbiology, Liège University Hospital, Belgium
- ↵*Correspondence to –
Thibaut Vanbaelen; Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium; tvanbaelen{at}itg.be; +32 (0) 3 345 58 14.
↵# These authors contributed equally
Posted August 16, 2023.
Does screening for Neisseria gonorrhoeae and Chlamydia trachomatis affect the incidence of these infections in men who have sex with men taking HIV pre-exposure prophylaxis (PrEP)Results from a randomized, multicentre controlled trial (the Gonoscreen study)
